Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
Recruiting in Palo Alto (17 mi)
+14 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: Mesoblast, Inc.
Trial Summary
What is the purpose of this trial?
The purpose of the study is to determine whether adult stem cells \[Provacel™(PUMP1)\] are safe and possibly effective in the treatment of acute myocardial infarction (heart attack).
Research Team
KB
Ken Borow, MD
Principal Investigator
Mesoblast, Inc.
Eligibility Criteria
Inclusion Criteria
Male or female between 21 and 85 years old
First heart attack within 1 to 10 days
Treatment Details
Interventions
- Provacel (Stem Cell Therapy)
Participant Groups
5Treatment groups
Active Control
Placebo Group
Group I: Provacel: Cohort 4Active Control1 Intervention
ex vivo cultured adult mesenchymal stem cells
Group II: Provacel: Cohort 1Active Control1 Intervention
ex vivo cultured adult mesenchymal stem cells
Group III: Provacel: Cohort 2Active Control1 Intervention
ex vivo cultured adult mesenchymal stem cells
Group IV: Provacel: Cohort 3Active Control1 Intervention
ex vivo cultured adult mesenchymal stem cells
Group V: PlaceboPlacebo Group1 Intervention
ex vivo cultured adult mesenchymal stem cells
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mesoblast, Inc.
Lead Sponsor
Trials
22
Recruited
2,400+